Retinitispigmentosa(RP)causesirreversibleblindnessinindividualsofallages.Itaffects~1in3,500people worldwide.WhileRPisinitiallycharacterizedbynightblindnessandperipheralvisionloss,mostRPpatients losetheircentralvisionandbecomelegallyblindbytheageof40.Thereisnotreatmenttosloworstop visionloss.Mislocalizationofthelight-absorbingproteinrhodopsinintherodsisacommonhallmarkshared bymanyanimalmodelsofRP.Thelong-termobjectiveofthisapplicationistodissectthemolecularpathway thatunderliesthesortinganddeliveryoftherhodopsinanddetermineitsdiseaserelevance.Thisinformation willacceleratethediscoveryofnewtreatmentsforRPandotherretinaldegenerativediseases.Inthe mammalianrods,whicharehighlycompartmentalized,rhodopsinissynthesizedinthebiosynthetic organellesconfinedtotheinnersegment.Rhodopsinisthenvectoriallydeliveredtoandconcentratedinthe outersegment(OS).Whilerhodopsin?straffickingthroughtheendoplasmicreticulum-Golgipathwayhas beeninvestigated,theimportanceoftheendosomeinrhodopsin?sOStargetingisunclear.Inmanyothercell types,theendosomes ervesasakeysortingstationforproteinsatthecrossroadsofmultipleintracellular traffickingpathways.Prolongedendosomalaccumulationofflyrhodopsinhasbeenshowntoleadtolight- dependentretinaldegeneration.Ourpreliminaryresultsshowedthatthenewly-synthesizedrhodopsin transitsthroughtheendosomalcompartmentsinmouserodsinvivo.TheOStargetingsignalofthe rhodopsinbindstoanearlyendosome-specificprotein,SARA.SARAdeficiencyinmouserodsnotonly causesrhodopsinmislocalizationbutalsoseveralothercellulardefectsintheendolysosomalsystem.Inthis application,wewilltestthecentralhypothesisthatinmammalianrodsthetrans-endosomalpathwaycritically regulatesthefidelityandtheefficiencyoftheOStargetingofrhodopsin.First,wewilladdresswhetherthe RPmutantrhodopsinsareretainedintheendosomesabnormallyduringtheirtransittotheOS,andwhether thisdefectperturbsthehomeostasisofotherendomembranes(Aim1).Wewillgeneratemultiple, complementarymousemodelstoexaminetheroleofthetrans-endosomalpathwayinthemorphogenesisof theOSanditsrhodopsinexpression(Aim2).Wewillalsoprofiletherodproteinsthattransitthroughthe endosomalsystemandcharacterizetheirinteractionwithkeyendosomaltraffickingregulators(Aim3).We willachievetheseaimsbyapplyingstate-of-the-arttechniquessuchasrod-specificinduciblegene expressionandgenedeletion,super-resolutionconfocalmicroscopy,correlativelight-electronmicroscopy, and3Dscanningelectronmicroscopy.Byprovidingmechanisticinsightsonphotoreceptorproteintrafficking andOSbiogenesis,thisresearchwillcontributetothedevelopmentofnewtherapiesforRPandrelated diseases.

Public Health Relevance

There is currently no treatment to slow or stop vision loss in patients with RP in which rhodopsin mislocalizaiton a common defect. The overall goal of this proposal is to demonstrate the critical importance of trans-endosomal pathway in regulating the high-fidelity sorting of rhodopsin and to identify novel endosomal trafficking regulators. Success in confirming our model will open new doors to rationale therapies that broadly treat RP and other retinal degenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY029428-01
Application #
9588863
Study Section
Biology of the Visual System Study Section (BVS)
Program Officer
Neuhold, Lisa
Project Start
2018-08-01
Project End
2022-04-30
Budget Start
2018-08-01
Budget End
2019-04-30
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065